Stifel raised the firm’s price target on CoreWeave (CRWV) to $120 from $115 and keeps a Hold rating on the shares after the company delivered “solid” Q2 results. Guidance was mixed with the revenue outlook higher-than-consensus for Q3 and FY25, but margin forecasts falling short, the analyst noted. While constructive long-term and “encouraged by today’s data points,” the firm sees near-term upside being capped by the potential dilution related to the Core Scientific (CORZ) deal as well as the pending lock-up expiration on Thursday, the analyst added.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CRWV:
- CoreWeave, Inc. Class A: Hold Rating Amid Strong Revenue but Margin and Debt Concerns
- CoreWeave price target raised to $105 from $60 at Wells Fargo
- CoreWeave, Inc. Class A: Balancing Strong Market Position with Valuation Concerns and External Uncertainties
- CoreWeave, Inc.: Balancing Strong Revenue Performance with Expansion Risks – Hold Rating Maintained
- ‘Not Worth Scaling’ and ‘Hold’: CoreWeave Stock Viewed Cautiously by Top Analysts After Mixed Q2